Determination of levofloxacin, norfloxacin, and moxifloxacin in pharmaceutical dosage form or individually using derivative UV spectrophotometry
- PMID: 38877570
- PMCID: PMC11179347
- DOI: 10.1186/s13065-024-01193-4
Determination of levofloxacin, norfloxacin, and moxifloxacin in pharmaceutical dosage form or individually using derivative UV spectrophotometry
Abstract
Purpose: In this study, first, second, third, and fourth-order derivative spectrophotometric methods utilizing the peak-zero (P-O) and peak-peak (P-P) techniques of measurement were developed for the determination of levofloxacin, norfloxacin, and moxifloxacin. These methods were applied to their combined pharmaceutical dosage form or individually for levofloxacin, norfloxacin, and moxifloxacin.
Methods: Linearity was established in the concentration range of 2-20 µg/mL. The procedures are simple, quick, and precise. The developed methods are sensitive, accurate, and cost-effective, demonstrating excellent correlation coefficients (R2 = 0.9998) and mean recovery values ranging from 99.20% to 100.08%, indicating a high level of precision.
Results: The developed approach was effectively employed to determine the levofloxacin, norfloxacin, and moxifloxacin content in commercially available pharmaceutical dosages.
Conclusions: Statistical analysis and recovery tests confirmed the method's linearity and accuracy. The results suggest that this method can be utilized for routine analysis in both bulk and commercial formulations. The simplicity, accuracy, and cost-effectiveness of the developed methods make them valuable for pharmaceutical analysis.
Keywords: Derivative Uv spectrophotometry; Levofloxacin; Moxifloxacin; Norfloxacin; Simultaneous estimation; Validation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interest.
Figures





Similar articles
-
Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations.J Pharm Anal. 2012 Dec;2(6):454-457. doi: 10.1016/j.jpha.2012.06.004. Epub 2012 Jul 8. J Pharm Anal. 2012. PMID: 29403782 Free PMC article.
-
Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometry.Chem Cent J. 2012 Sep 20;6(1):105. doi: 10.1186/1752-153X-6-105. Chem Cent J. 2012. PMID: 22995678 Free PMC article.
-
Development and validation of column high-performance liquid chromatographic and derivative spectrophotometric methods for determination of levofloxacin and ornidazole in combined dosage forms.J AOAC Int. 2008 Jul-Aug;91(4):756-61. J AOAC Int. 2008. PMID: 18727534
-
Kinetic spectrophotometric method for the determination of norfloxacin in pharmaceutical formulations.Eur J Pharm Biopharm. 2004 Mar;57(2):359-67. doi: 10.1016/S0939-6411(03)00192-9. Eur J Pharm Biopharm. 2004. PMID: 15018997
-
Determination of two antibacterial binary mixtures by chemometrics-assisted spectrophotometry.J AOAC Int. 2007 Jan-Feb;90(1):128-41. J AOAC Int. 2007. PMID: 17373443
Cited by
-
Metal chelation approach synergized with surfactant for spectrofluorimetric assay of moxifloxacin with method greenness evaluation.BMC Chem. 2025 Jul 15;19(1):212. doi: 10.1186/s13065-025-01580-5. BMC Chem. 2025. PMID: 40665380 Free PMC article.
References
-
- Redasani VK, Patel PR, Marathe DY, Chaudhari SR, Shirkhedkar AA, Surana SJ. A review on derivative UV-spectrophotometry analysis of drugs in pharmaceutical formulations and biological samples. J Chil Chem Soc. 2018;63(3):4126–4134. doi: 10.4067/s0717-97072018000304126. - DOI
-
- Ojeda CB, Rojas FS. Recent developments in derivative ultraviolet/visible absorption spectrophotometry. Anal Chim Acta. 2004;518(1–2):1–24. doi: 10.1016/j.aca.2004.04.031. - DOI
-
- Karpinska, J. Basic principles and analytical application of derivative spectrophotometry. Macro to nano spectroscopy, Macro to nano spectroscopy, book edited by Jamal Uddin (2012):253–256.
LinkOut - more resources
Full Text Sources
Miscellaneous